MiNK Therapeutics

New York, United States

MiNK Therapeutics is a biopharmaceutical company developing allogeneic iNKT cell therapies and immune technologies for treatment.

Jun 2025

Grant

Biopharma Biotechnology Manufacturing Therapeutics

Top Investors

National Institute of Allergy and Infectious DiseasesGKCC

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about MiNK Therapeutics

Who are MiNK Therapeutics's investors?

MiNK Therapeutics's investors include National Institute of Allergy and Infectious Diseases, GKCC.

Where is MiNK Therapeutics headquartered?

MiNK Therapeutics is headquartered in New York, United States.

What does MiNK Therapeutics do?

MiNK Therapeutics is a biopharmaceutical company developing allogeneic iNKT cell therapies and immune technologies for treatment.

What stage is MiNK Therapeutics at?

MiNK Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 2, 2025.

MLA

"MiNK Therapeutics — Funding & Investors." VCBacked, June 2, 2025, https://www.vcbacked.co/company/mink-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2025). MiNK Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/mink-therapeutics

Wikipedia (cite web)

{{cite web |title=MiNK Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mink-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 2, 2025.

Similar Companies in Biopharma

View all

Living In Silico Inc.

Crystalys Therapeutics

San Diego

ARS Pharmaceuticals

San Diego